⌘K

Login Start Free

Home/Filings/4/0000899243-21-004890

4//SEC Filing

Dalal Anupam 4

Accession 0000899243-21-004890

CIK 0001422142other

View on SEC.gov Company Profile

Filed

Feb 2, 7:00 PM ET

Accepted

Feb 3, 9:34 PM ET

Size

5.3 KB

Accession

0000899243-21-004890

Insider Transaction Report

Form 4

Period: 2021-02-01

Aerpio Pharmaceuticals, Inc.ARPO

Director

Transactions

Award
Stock Option (Right to Buy)
2021-02-01+17,857→ 17,857 total
Exercise: $1.46Exp: 2031-02-01→ Common Stock (17,857 underlying)

Footnotes (1)

[F1]Options shall vest in four equal quarterly installments beginning on February 1, 2021.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Aerpio Pharmaceuticals, Inc.

CIK 0001422142

Entity typeother

Related Parties

1

filerCIK 0001602474

Filing Metadata

Form type: 4
Filed: Feb 2, 7:00 PM ET
Accepted: Feb 3, 9:34 PM ET
Size: 5.3 KB

View on SEC.gov